Brain metastasis in head and neck squamous cell carcinoma after immune check point inhibitors treatment

被引：1
|
作者：
Lorini, Luigi [1 ]
Merlano, Marco [2 ,3 ]
Licitra, Lisa [4 ]
Ravanelli, Marco [5 ]
Bossi, Paolo [6 ]
机构：
[1] Univ Brescia, Dept Med & Surg Specialties Radiol Sci & Publ Hlt, Med Oncol Unit, Brescia, Italy
[2] Translat Res ARCO Fdn Cuneo, Cuneo, Italy
[3] FPO IRCCS Candiolo, Candiolo Canc Inst, Turin, Italy
[4] Fdn IRCCS Ist Nazl Tumori Milano, Head & Neck Med Oncol Dept, Milan, Italy
[5] Univ Brescia, Dept Radiol, Brescia, Italy
[6] Univ Brescia, ASST Spedali Civili, Dept Med & Surg Specialties Radiol Sci & Publ Hlt, Med Oncol, Brescia, Italy
来源：
ORAL ONCOLOGY | 2021年 / 116卷
关键词：
LOCALLY ADVANCED HEAD; NIVOLUMAB; CHEMOTHERAPY; RECURRENT; PATTERNS; CANCERS; PATIENT;
D O I：
10.1016/j.oraloncology.2020.105138
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Metastatic head and neck squamous cell carcinoma to the brain
    Djalilian, HR
    Tekin, M
    Hall, WA
    Adams, GL
    AURIS NASUS LARYNX, 2002, 29 (01) : 47 - 54
  • [22] Treatment results of regional metastasis from cutaneous head and neck squamous cell carcinoma
    Jol, JAD
    van Velthuysen, MLF
    Hilgers, FJM
    Keus, RB
    Neering, H
    Balm, AJM
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2003, 29 (01): : 81 - 86
  • [23] Brain metastasis from squamous cell carcinoma of the head and neck: a review of the literature in the genomic era
    Barrett, Thomas F.
    Gill, Corey M.
    Miles, Brett A.
    Iloreta, Alfred M. C.
    Bakst, Richard L.
    Fowkes, Mary
    Brastianos, Priscilla K.
    Bederson, Joshua B.
    Shrivastava, Raj K.
    NEUROSURGICAL FOCUS, 2018, 44 (06)
  • [24] Pulmonary squamous cell carcinoma following head and neck squamous cell carcinoma: Metastasis or second primary?
    Geurts, TW
    Nederlof, PM
    van den Brekel, MWM
    van't Veer, LJ
    de Jong, D
    Hart, AAM
    van Zandwijk, N
    Klomp, H
    Balm, AJM
    van Velthuysen, MLF
    CLINICAL CANCER RESEARCH, 2005, 11 (18) : 6608 - 6614
  • [25] Pulmonary squamous cell carcinoma following head and neck squamous cell carcinoma: Metastasis or second primary?
    不详
    VIRCHOWS ARCHIV, 2005, 447 (02) : 131 - 132
  • [26] Genomic correlates of response to immune checkpoint inhibitors in advanced head and neck squamous cell carcinoma
    Patel, Nisarg A.
    Vokes, Natalie, I
    Elmarakeby, Haitham
    Hanna, Glenn J.
    Van Allen, Eliezer M.
    CANCER RESEARCH, 2020, 80 (16)
  • [27] Immune checkpoint inhibitors for head and neck squamous cell carcinoma: Current landscape and future directions
    Kao, Hsiang-Fong
    Lou, Pei-Jen
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 : 4 - 18
  • [28] Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with squamous cell carcinoma of the head and neck.
    Saleh, Khalil
    Daste, Amaury
    Martin, Nicolas
    Pons-Tostivint, Elvire
    Auperin, Anne
    Herrera-Gomez, Ruth Gabriela
    Baste, Neus
    Bidault, Francois
    Guigay, Joel
    Le Tourneau, Christophe
    Saada, Esma
    Even, Caroline
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [29] Profiles of immune cell infiltration in head and neck squamous carcinoma
    Liang, Bin
    Tao, Ye
    Wang, Tianjiao
    BIOSCIENCE REPORTS, 2020, 40
  • [30] Obesity and Survival After Immune Checkpoint Inhibition for Head and Neck Squamous Cell Carcinoma
    Mastrolonardo, Eric V.
    Llerena, Pablo
    Lu, Joseph
    Nunes, Kathryn
    Choi, Grace K.
    Amin, Dev
    Bridgham, Kelly M.
    Campbell, Daniel
    Philips, Ramez
    Cognetti, David M.
    Luginbuhl, Adam J.
    Curry, Joseph M.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2024,
12345